Dr. Agarwal's Healthcare, a well-known name in India's eye care industry, is all set to launch its Initial Public Offering (IPO) between January 29 and 31, 2025. The company has priced its shares in the range of ₹382 to ₹402, aiming to raise around ₹3,027 crores. Investors looking for opportunities in the growing healthcare sector need to assess whether this IPO is worth investing in. This article breaks down the company's strengths, financials, risks, and potential returns to help you make an informed decision. About Dr. Agarwal’s Healthcare Dr. Agarwal’s Healthcare is a leading eye care chain in India, offering a wide range of services, including: Routine eye checkups Cataract and LASIK surgeries Treatment for glaucoma and retinal diseases Advanced eye care solutions With more than 140 hospitals across India and a presence in several international markets, the company has built a strong brand reputation in the healthcare space. What Sets Dr. Agarwal’s Apart? Specialized ...